Ko Nakajo
- Co-authors
- Yoji MorisakiHiroshi NishiuraHidehisa SaekiHidemi NakagawaOlawale OsuntokunTaeko IshiiGregory S. CameronHany Elmaraghy
- Topics
- COVID-19 epidemiological studies (4 papers)Psoriasis: Treatment and Pathogenesis (4 papers)Eosinophilic Esophagitis (3 papers)
- Journals
- The Journal of Infectious DiseasesWorld Journal of GastroenterologyFrontiers in Pharmacology
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Ko Nakajo
15 papers receiving 322 citations
Peers
Comparison fields: 5 of 54
- Immunology 224
- Dermatology 172
- Physiology 78
- Pathology and Forensic Medicine 59
- Rheumatology 39
Countries citing papers authored by Ko Nakajo
This map shows the geographic impact of Ko Nakajo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ko Nakajo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ko Nakajo more than expected).
Fields of papers citing papers by Ko Nakajo
This network shows the impact of papers produced by Ko Nakajo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ko Nakajo. The network helps show where Ko Nakajo may publish in the future.
Co-authorship network of co-authors of Ko Nakajo
This figure shows the co-authorship network connecting the top 25 collaborators of Ko Nakajo. A scholar is included among the top collaborators of Ko Nakajo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ko Nakajo. Ko Nakajo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 11 | |
| 7 | 3 | |
| 8 | 3 | |
| 9 | 8 | |
| 10 | 6 | |
| 11 | 22 | |
| 12 | 5 | |
| 13 | 28 | |
| 14 | 49 | |
| 15 | 156 | |
| 16 | 21 | |
| 17 | 6 | |
| 18 | [The analysis of the sensitivity and the specificity of the mass screening system of BSE]. | 1 |
About Ko Nakajo
Ko Nakajo is a scholar working on Modeling and Simulation, Dermatology and Infectious Diseases, having authored 18 papers that have together received 325 indexed citations. Recurring topics across this work include COVID-19 epidemiological studies (4 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Eosinophilic Esophagitis (3 papers). The work is most often cited by research in Dermatology (172 citations), Immunology (224 citations) and Modeling and Simulation (32 citations). Ko Nakajo has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yoji Morisaki, Hiroshi Nishiura, Hidehisa Saeki, Hidemi Nakagawa, Olawale Osuntokun, Taeko Ishii, Gregory S. Cameron, Hany Elmaraghy, Hitoe Torisu‐Itakura and Tomotaka Mabuchi. Their work appears in journals such as The Journal of Infectious Diseases, World Journal of Gastroenterology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.